Sr. Director, Clinical Pharmacology & Pharmacometrics

GONDOLABIO SERVICECO INC

California

Híbrido

USD 300 000 - 420 000

Tempo integral

14 dias+

Uma candidatura completa num minuto

Currículo e carta de apresentação personalizados, prontos a enviar.

Ultrapassa os filtros ATS

Resumo da oferta

GondolaBio is seeking an experienced Sr. Director of Clinical Pharmacology & Pharmacometrics to shape strategy for oligonucleotide programs. Remote U.S. or on-site/hybrid Palo Alto options available, reporting to the Chief Development Officer.

You will lead first-in-human dose selection, translate nonclinical data to clinical plans, and guide modeling-based decision making across all development stages, building a robust pharmacology and pharmacometrics framework in a fast-moving biotech.

Qualificações

  • PhD or equivalent in Pharmacometrics, Quantitative & Clinical Pharmacology or related field.
  • 10+ years of industry experience in clinical pharmacology and/or pharmacometrics.

Responsabilidades

  • Own the clinical pharmacology strategy and development plan for each program from IND through NDA/MAA.
  • Lead first-in-human dose selection and escalation using nonclinical PK/PD and translational data.
  • Perform and oversee translational PK/PD modeling to enable FIH dose and early efficacy/safety characterization.
  • Lead pharmacometrics strategies across drug development incl. population PK/PKPD and exposure–response modeling.

Conhecimentos

Clinical pharmacology leadership
Quantitative pharmacology
MIDD
PK/PD modeling
Regulatory interactions

Formação académica

PhD in Pharmacometrics or related field

Ferramentas

NONMEM
Population PK/PD software

Descrição da oferta de emprego

All Jobs > Sr. Director, Clinical Pharmacology & Pharmacometrics

Sr. Director, Clinical Pharmacology & Pharmacometrics
Fully Remote CA

Full-time

Description

Sr. Director, Clinical Pharmacology & Pharmacometrics

Reports to: Chief Development Officer

Location: Remote U.S. or On-site/Hybrid Palo Alto

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics for genetic diseases. GondolaBio is an independent sister company to BridgeBio, originally carved out in 2024 after securing $300M in private financing from external investors. GondolaBio aims to leverage cutting-edge biological research to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases.

The Role

You are an experienced clinical pharmacology and quantitative pharmacology leader with deep expertise in early clinical development and a strong track record of informing dose selection and development decisions for oligonucleotide therapies. You are comfortable setting strategy at the portfolio and program level while also rolling up your sleeves to execute in a small, fast-moving biotech environment, and you are energized by the opportunity to help build and shape clinical pharmacology and pharmacometrics approaches as the company and pipeline grow.

A successful candidate must have a demonstrated track-record of driving success in translational research, clinical pharmacology, MIDD and regulatory negotiations as an individual contributor and team leader in oligonucleotides. Key areas of emphasis will include but are not limited to clinical dose selection and refinement across all phases of clinical development, FIH and clinical pharmacology study design, development and hands-on application of MIDD using population and statistical framework, as well as mechanistic and translational PK/PD approaches.

Key Responsibilities
  • Own the clinical pharmacology strategy and development plan for each program, from IND through NDA/MAA.
  • Lead first-in-human dose selection and escalation, integrating nonclinical PK/PD, toxicology, and translational data.
  • Personally perform and oversee translational and mechanistically based PK/PD modeling to enable identification of FIH dose, early characterization of efficacy and safety using biomarkers and disease animals.
  • Lead and execute pharmacometrics strategies across all stages of drug development, including population PK, PK/PD, and exposure-response modeling and simulation, meta-analysis, disease modeling to inform clinical development.
  • Support nonclinical PK/PD, ADME and DMPK evaluations including strategy development, data analysis and integration.
  • Design and interpret clinical pharmacology studies and analyses, including renal/hepatic impairment, immunogenicity impact, and concentration-QTc strategy. Develop and execute pediatric dosing and extrapolation strategies appropriate to rare disease populations.
  • Author and review clinical pharmacology content for regulatory documents: IND/CTA, Investigator’s Brochure, protocols, briefing packages, CSRs, and Module 2.7.2 summaries.
  • Represent as functional area lead in FDA, EMA, and other health authority interactions, including starting dose rationale, dose escalation design, SAD/MAD strategy, and integration of nonclinical and translational data from IND to NDA/BLA.
  • Encompass leading-edge knowledge in clinical pharmacology and pharmacometrics discipline, publish manuscripts. Advocate scientific leadership at external conferences and scientific community
Requirements
  • PhD in Pharmacometrics, Quantitative & Clinical Pharmacology, Pharmaceutical sciences, or a related field.
  • [10+] years of industry clinical pharmacology and/or pharmacometrics experience,
Obtém a tua avaliação gratuita e confidencial do currículo.

ou arrasta e larga o ficheiro aqui.

Similar jobs

Ofertas semelhantes que vale a pena comparar

Sr. Director, Clinical Pharmacology & Pharmacometrics
Sr. Director, Clinical Pharmacology & Pharmacometrics

GondolaBio, LLC • Palo Alto (CA)

Híbrido
USD 250 000 - 380 000
Senior Director, Clinical Pharmacology & Pharmacometrics — Remote
Senior Director, Clinical Pharmacology & Pharmacometrics — Remote

GONDOLABIO SERVICECO INC • California

Híbrido
USD 300 000 - 420 000
Sr. Director, Clinical Pharmacology & Pharmacometrics
Sr. Director, Clinical Pharmacology & Pharmacometrics

GondolaBio Service Co, Inc. • Palo Alto (CA)

Híbrido
USD 285 000 - 325 000
Equity and comprehensive benefits
Flexible PTO
Remote Senior Director, Clinical Pharmacology & Pharmacometrics
Remote Senior Director, Clinical Pharmacology & Pharmacometrics

GondolaBio, LLC • Palo Alto (CA)

Híbrido
USD 250 000 - 380 000
Director, Clinical PK & Pharmacometrics — Strategy Leader
Director, Clinical PK & Pharmacometrics — Strategy Leader

GondolaBio Service Co, Inc. • Palo Alto (CA)

Híbrido
USD 285 000 - 325 000
Equity and comprehensive benefits
Flexible PTO
Remote Principal Scientist, In Vivo Neuropharmacology
Remote Principal Scientist, In Vivo Neuropharmacology

GondolaBio, LLC • Palo Alto (CA)

Híbrido
USD 173 000 - 205 000
Patient Days
Equity and bonus plan
Flexible PTO
+1
Principal Scientist, In Vivo Pharmacology, Neurology
Principal Scientist, In Vivo Pharmacology, Neurology

GondolaBio, LLC • Palo Alto (CA)

Híbrido
USD 173 000 - 205 000
Patient Days
Equity and bonus plan
Flexible PTO
+1
Associate Director/Director, Regulatory Affairs
Associate Director/Director, Regulatory Affairs

GondolaBio, LLC • EUA

Teletrabalho
USD 200 000 - 240 000
Flexible PTO
Health benefits and retirement options
Competitive compensation
Director, Clinical Pharmacology
Director, Clinical Pharmacology

Meet Life Sciences • California

Teletrabalho
USD 230 000 - 320 000
Associate Director, Quantitative Clinical Pharmacology
Associate Director, Quantitative Clinical Pharmacology

Simulations Plus • EUA

Teletrabalho
USD 135 000 - 175 000
Fully remote work
Flexible schedules
Generous vacation policy
+2